- Home
- LILAK vs ZLAB Comparison
LILAK vs ZLAB Comparison
Compare LILAK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILAK
- ZLAB
- Stock Information
- Founded
- LILAK 2017
- ZLAB 2013
- Country
- LILAK Bermuda
- ZLAB China
- Employees
- LILAK N/A
- ZLAB N/A
- Industry
- LILAK Cable & Other Pay Television Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- LILAK Telecommunications
- ZLAB Health Care
- Exchange
- LILAK Nasdaq
- ZLAB Nasdaq
- Market Cap
- LILAK 1.1B
- ZLAB 3.6B
- IPO Year
- LILAK N/A
- ZLAB 2017
- Fundamental
- Price
- LILAK $6.05
- ZLAB $35.00
- Analyst Decision
- LILAK Buy
- ZLAB Buy
- Analyst Count
- LILAK 3
- ZLAB 5
- Target Price
- LILAK $10.27
- ZLAB $54.28
- AVG Volume (30 Days)
- LILAK 991.3K
- ZLAB 1.0M
- Earning Date
- LILAK 08-05-2025
- ZLAB 08-05-2025
- Dividend Yield
- LILAK N/A
- ZLAB N/A
- EPS Growth
- LILAK N/A
- ZLAB N/A
- EPS
- LILAK N/A
- ZLAB N/A
- Revenue
- LILAK $4,441,000,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- LILAK $2.45
- ZLAB $44.07
- Revenue Next Year
- LILAK $3.11
- ZLAB $49.13
- P/E Ratio
- LILAK N/A
- ZLAB N/A
- Revenue Growth
- LILAK N/A
- ZLAB 43.72
- 52 Week Low
- LILAK $4.23
- ZLAB $16.01
- 52 Week High
- LILAK $10.93
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- LILAK 64.18
- ZLAB 51.28
- Support Level
- LILAK $5.78
- ZLAB $34.44
- Resistance Level
- LILAK $6.09
- ZLAB $38.18
- Average True Range (ATR)
- LILAK 0.22
- ZLAB 1.33
- MACD
- LILAK 0.07
- ZLAB -0.44
- Stochastic Oscillator
- LILAK 92.86
- ZLAB 17.66
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.